Valve disease and pulmonary arterial hypertension due to appetite suppressants (update)
Prescrire international 9(45): 211
2000
ISSN/ISBN: 1167-7422 PMID: 11503800 Document Number: 512546
(1) The unfavourable risk-benefit ratio of amphetamine appetite suppressants has led the French medicines agency to withdraw their marketing authorisation.
Document emailed within 1 workday
Related Documents
Adams, C.; Cohen, A. 1999: Appetite suppressants and heart valve disorders Archives des Maladies du Coeur et des Vaisseaux 92(9): 1213-1219Widgren, S. 1975: Pulmonary arterial hypertension in patients treated with appetite depressants in Switzerland Verhandlungen der Deutschen Gesellschaft für Pathologie 59: 548
Berthou, J.D.; Delahaye, J.P.; Brune, J.; Dorsit, G.; Delaye, J.; Roques, J.C.; Gonin, A. 1972: Apparently primary pulmonary arterial hypertension in a woman who had taken appetite depressants (Aminorex) Revue de Tuberculose et de Pneumologie 36(6): 944-951
Fong Chee Yee; Singham, K.T. 1986: Pulmonary valve echocardiogram in the evaluation of pulmonary arterial hypertension in the presence of intracardiac shunts Medical Journal of Malaysia 41(3): 198-204
De Meester, P.; Van De Bruaene, A.; Delcroix, M.; Belmans, A.; Herijgers, P.; Voigt, J-Uwe.; Budts, W. 2012: Pulmonary arterial pressure and right ventricular dilatation independently determine tricuspid valve insufficiency severity in pre-capillary pulmonary hypertension Journal of Heart Valve Disease 21(6): 743-748
Lasagna, L. 1973: Attitudes toward appetite suppressants. a survey of US physicians JAMA 225(1): 44-48
Levens, N.; Della-Zuana, O. 2003: Appetite suppressants: problems and pitfalls of drug discovery Current Opinion in Investigational Drugs 4(4): 384-385
Obiditsch-Mayer, I. 1972: Pulmonary hypertension following appetite depressants Die Medizinische Welt 23(29): 1043-1044
Widimský, J. 1983: Pulmonary precapillary hypertension in mitral valve disease Cor et Vasa 25(1): 17-27
Mucke, H.A.M. 2008: Pulmonary arterial hypertension: on the way to a manageable disease Current Opinion in Investigational Drugs 9(9): 957-962
Marozsán, I.; Szatmáry, L.; Kelemen, S. 1989: Hemodynamic effects of verapamil in pulmonary hypertension caused by heart valve disease Orvosi Hetilap 130(18): 945-948
Batyraliev, T.A.; Makhmutkhodzhaev, S.A.; Ekinsi, E.; Pataraia, S.A.; Pershukov, I.V.; Sidorenko, B.A.; Preobrazhenskiĭ, D.V. 2007: Pulmonary hypertension and right ventricular failure. Part XI. Endothelin receptor blockers in the treatment of primary pulmonary arterial hypertension Kardiologiia 47(7): 73-82
Batyraliev, T.A.; Makhmutkhodzhaev, S.A.; Ekence, E.; Pataraia, S.A.; Pershukov, I.V.; Sidorenko, B.A.; Preobrezhenskiĭ, D.V. 2007: Pulmonary hypertension and right ventricular failure. Part VIII. Diagnosis, course, and prognosis of primary (idiopathic) pulmonary arterial hypertension Kardiologiia 47(3): 69-78
Goldstein, S.E.; Levy, Y.; Shoenfeld, Y. 1998: Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants Harefuah 135(11): 489-492; 568
Ji, Y.-q.; Zhang, Z.-l.; Lu, W.-x. 2006: The clinical analysis of pulmonary arterial hypertension in connective tissue disease Zhonghua Nei Ke Za Zhi 45(6): 467-471
Bouhanick, B.; Marre, M.; Laporte, J.; Bigorgne, J.C.; Fressinaud, P. 1990: Primary pulmonary arterial hypertension and auto-immune multiple endocrine disease Presse Medicale 19(26): 1242-1243
Durongpisitkul, K.; Jakrapanichakul, D.; Sompradikul, S. 2008: A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease Journal of the Medical Association of Thailand 91(2): 196-202
Weitzenblum, E.; Hirth, C.; Ducolone, A.; Mirhom, R.; Rasaholinjanahary, J.; Pelletier, A. 1981: The prognostic significance of pulmonary arterial hypertension in chronic obstructive airway disease Le Poumon et le Coeur 37(3): 177-184
Conradi, L.; Schaefer, A.; Mueller, G.C.; Seiffert, M.; Gulbins, H.; Blankenberg, S.; Reichenspurner, H.; Treede, H.; Diemert, P. 2015: Carcinoid Heart Valve Disease: Transcatheter Pulmonary Valve-In-Valve Implantation in Failing Biological Xenografts Journal of Heart Valve Disease 24(1): 110-114
von Smekal, P.; Standfuss, K.; Rau, G. 1970: Increase of primary vascular pulmonary hypertension in connection with the intake of appetite depressants? Questions of respiratory regulation Zeitschrift für Kreislaufforschung 59(10): 892-897